por Lynn Shapiro
, Writer | January 12, 2009
Abbott Laboratories said it would acquire Advanced Medical Optics Inc. for $1.36 billion, boosting Abbott's already formidable presence in the eye care business.
Abbott will pay $22 per share in cash for AMO, more than double the share's closing price last Friday of $8.85. This is considered to be an inexpensive acquisition for Abbott, considering Advanced Medical Optics was trading at about $22 several months ago.
"Abbott will immediately become a global leader in vision," said vice president John M. Capek. "The business is poised for long-term growth, driven by advances in refractive surgery technologies, including Lasik, and an aging global population," Capek added.
Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.
Advanced Medical is the world's largest company dealing in Lasik surgical devices, the second largest player in the cataract surgical-device market and third in contact-lens solutions.
The market for cataract surgery is expected to grow by approximately 50% in the next decade as the population ages, the company said.
Last week, Abbott also said it would team up with Liquidia Technologies, a nanotechnology company, to develop cancer drugs.